<DOC>
	<DOCNO>NCT00000847</DOCNO>
	<brief_summary>To evaluate safety immunogenicity high-titered ALVAC-HIV MN120TMG ( vCP205 ) give sequentially simultaneously rgp120/HIV-1SF2 MF59 adjuvant emulsion HIV-negative volunteer . ALVAC-HIV vCP205 second-generation candidate vaccine use induce humoral cellular response several antigen . vCP205 express proteins two strain HIV ( MN LAI ) . rgp120/HIV-1SF2 express proteins different strain HIV . This study help show immune system respond proteins one strain virus .</brief_summary>
	<brief_title>A Phase I Safety Immunogenicity Trial Live Recombinant Canarypox ALVAC-HIV ( vCP205 ) HIV-1 SF-2 rgp120 HIV-1 Uninfected Adult Volunteers</brief_title>
	<detailed_description>ALVAC-HIV vCP205 second-generation candidate vaccine use induce humoral cellular response several antigen . vCP205 express proteins two strain HIV ( MN LAI ) . rgp120/HIV-1SF2 express proteins different strain HIV . This study help show immune system respond proteins one strain virus . Six group 25 volunteer randomize receive simultaneous sequential dos ALVAC-HIV vCP205 SF2 rgp120 control vaccine ( ALVAC-RG rabies glycoprotein vCP65 BIOCINE Placebo Vaccine 2 ) . In group , 21 volunteer receive vaccine 4 receive control vaccine . Volunteers stratify low high risk sexual behavior . Immunizations give three group month 0 , 1 , 3 , 6 , 9 , 12 , three group month 0 , 1 , 6 , 9 , 12 . Volunteers follow 24 month .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Krestin</mesh_term>
	<criteria>Inclusion Criteria Volunteers must : Normal history physical exam . Negative ELISA Western blot HIV . CD4 count &gt; = 400 cells/mm3 . Normal urine dipstick esterase nitrite . NOTE : No 10 percent volunteer stratum may age 50 . Risk Behavior : Allowed volunteer stratify high risk stratum : High risk behavior HIV infection , injection drug use within past 12 month . high intermediate risk sexual behavior . Exclusion Criteria Coexisting Condition : Subjects follow symptoms condition exclude : Positive hepatitis B surface antigen . Medical psychiatric condition ( recent suicidal ideation present psychosis ) preclude compliance . Occupational responsibility preclude compliance . Active syphilis . NOTE : Subjects serology document false positive due remote ( &gt; 6 month ) treat infection eligible . Active tuberculosis . NOTE : Subjects positive PPD normal chest xray show evidence TB require isoniazid therapy eligible . Allergy egg product neomycin . Occupational exposure bird . Subjects follow prior condition exclude : History immunodeficiency , chronic illness , autoimmune disease , use immunosuppressive medication . History anaphylaxis serious adverse reaction vaccine . Prior immunization rabies . History serious allergic reaction substance , require hospitalization emergent medical care ( e.g. , StevensJohnson syndrome , bronchospasm , hypotension ) . Prior psychiatric condition ( history suicide attempt past psychosis ) preclude compliance . History cancer unless surgical excision consider achieved cure . Prior Medication : Excluded : Live attenuate vaccine within 60 day prior study entry . NOTE : Medically indicate kill subunit vaccine ( e.g. , influenza , pneumococcal ) exclude administer least 2 week HIV immunization . Experimental agent within 30 day prior study entry . Prior HIV vaccine . Prior rabies immunization . Prior Treatment : Excluded : Blood product immunoglobulin within past 6 month . For volunteer stratify low risk stratum : High risk behavior HIV infection , injection drug use within past 12 month . high intermediate risk sexual behavior .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Vaccines , Synthetic</keyword>
	<keyword>HIV Envelope Protein gp120</keyword>
	<keyword>AIDS Vaccines</keyword>
	<keyword>HIV Seronegativity</keyword>
	<keyword>Avipoxvirus</keyword>
	<keyword>HIV Preventive Vaccine</keyword>
</DOC>